The Obamacare Rollout: What Worked and What Didn't | Market Check-Up, 10/4/13 | The Motley Fool | Summary and Q&A

TL;DR

Discovery Labs experiences a 40% increase after FDA approval, while Obamacare exchanges show high demand and lower-than-expected premiums.

Key Insights

• ❓ Discovery Labs' stock price soared after the FDA approval of their drug surfaxin, which prevents a breathing condition in infants.
• ✋ Obamacare exchanges experienced high demand, with millions of unique visitors and calls to call centers, suggesting a strong interest in obtaining insurance coverage.
• 😘 Premiums for Obamacare coverage came in lower than expected, which is positive news for consumers.

Transcript

a biotech pop and ObamaCare back in the news it's headline Deja Vu on your Market checkup hi fools I'm Max Macaluso and joining me today are David Williamson Healthcare analyst here and our director of investment planning Dan kaplinger so guys let's start with the biotech pop and David this is Discovery Labs it's up almost 40% today on an FDA decis... Read More

Questions & Answers

Q: Why did Discovery Labs see such a significant increase in stock price?

Discovery Labs saw a surge because their drug, surfaxin, was finally approved by the FDA after multiple rejections. This drug has the potential to prevent a life-threatening condition in infants.

Q: How have Obamacare exchanges performed in terms of demand?

Obamacare exchanges experienced high demand, with millions of unique visitors and calls to call centers. This suggests that there is a significant interest in obtaining insurance coverage through these exchanges.

Q: Why were premiums for Obamacare coverage lower than projected?

The premiums for Obamacare coverage came in lower than expected. This is positive news for consumers as it means they can access affordable coverage. It also indicates that the program may be working effectively in terms of cost control.

Q: Are there any concerns or challenges with Obamacare exchanges?

There were some glitches and technical issues with the exchanges, as they struggled to handle the high demand and traffic. However, efforts are being made to address these issues and optimize the system over time.

Summary & Key Takeaways

• Discovery Labs sees a significant increase in stock price after FDA approval of their drug, surfaxin, which prevents a potentially fatal breathing condition in infants.

• Obamacare exchanges show high demand, with millions of unique visitors and calls to call centers.

• Premiums for insurance coverage under Obamacare are lower than projected.